Posted 18 February, 2021
Virpax Pharmaceuticals, Inc. IPO completed
IPO completed detected for ticker Nasdaq:VRPX in a 424B4 filed on 18 February, 2021.
This is a firm commitment initial public offering of 1,800,000 shares of Virpax Pharmaceuticals, Inc. common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Virpax Pharmaceuticals, Inc.
Health Care/Life Sciences • Pharmaceuticals
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.Market Cap
$4.41M
View Company Details
$4.41M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.